home / stock / gene / gene news

GENE News and Press, Genetic Technologies Ltd From 05/23/23

Stock Information
Company Name: Genetic Technologies Ltd
Stock Symbol: GENE
Market: NASDAQ
Website: gtglabs.com
Menu
GENE GENE Quote GENE Short GENE News GENE Articles GENE Message Board
Get GENE Alerts

News, Short Squeeze, Breakout and More Instantly...
GENE - GeneType featured on U.S. National TV to raise Breast Cancer Awareness

MELBOURNE, Australia, May 23, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and serious disease is pleased to announce that the Company’s geneType Brea...
GENE - Genetic Technologies Limited (GENE) Q3 2023 Earnings Call Transcript

2023-05-03 23:45:09 ET Genetic Technologies Limited (GENE) Q3 2023 Earnings Conference Call May 03, 2023 05:00 PM ET Company Participants Adrian Mulcahy - Investor Relations Simon Morriss - Chief Executive Officer Tony Di Pietro - Chief Financial Officer Co...

GENE - New Publication Validates geneType for Melanoma Risk Assessment

MELBOURNE, Australia, April 28, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and serious disease is pleased to announce the publication of a research paper i...

GENE - Quarterly Business Update - March 2023

MELBOURNE, Australia, April 27, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, ”Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, releases its Appendix 4C and Quarterly b...
GENE - Publication Validates geneType Prostate Cancer Risk Test

MELBOURNE, Australia, April 19, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and serious disease is pleased to announce the publication of a research paper i...

GENE - GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation

MELBOURNE, Australia, March 27, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) – a global leader in genomics-based tests in health, wellness and serious disease – is pleased to announce the US launch of th...

GENE - Genetic highlights study suggesting geneType test's superiority in detecting breast cancer risk

2023-03-13 09:46:33 ET Genetic Technologies ( NASDAQ: GENE ) said a research paper published in the journal Cancer Prevention Research supports the use of geneType Breast Cancer risk assessment test. The paper titled, Validation of an abridged breast cancer ris...
GENE - Back-to-back Studies Validate geneType Breast Cancer Risk Test

MELBOURNE, Australia, March 13, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the publication of another research...

GENE - Genetic Technologies Limited (GENE) Q2 2023 Earnings Call Transcript

Genetic Technologies Limited (GENE) Q2 2023 Earnings Conference Call Feb 27, 2023, 05:00 PM ET Company Participants Adrian Mulcahy - Investor Relations Simon Morriss - CEO Tony Di Pietro – CFO Carl Stubbings - Chief Commercial Officer Conference Call P...

GENE - Genetic stock surges ~20% as study suggests geneType tests detects breast cancer earlier

Genetic Technologies ( NASDAQ: GENE ) stock rose ~20% on Thursday after the company announce the publication of a research paper in a journal suggesting geneType's ability to detect breast cancer earlier and provide data for risk stratification. The paper — which was p...
Previous 10 Next 10